...
首页> 外文期刊>Disease markers >Luminoimmunometric Assay of Tissue Polypeptide Antigen (Tpa) and Cancer Antigen 125 (Ca-125) in Breast Cancer Patients
【24h】

Luminoimmunometric Assay of Tissue Polypeptide Antigen (Tpa) and Cancer Antigen 125 (Ca-125) in Breast Cancer Patients

机译:乳腺癌患者组织多肽抗原(Tpa)和癌症抗原125(Ca-125)的光免疫测定

获取原文

摘要

Serum TPA and CA-125 were determined in 86 individuals (66 with breast cancer representing the different stages and grades of the disease and 20 normal healthy controls). TPA and CA-125 were estimated using the L1A reagents supplied by BYK Sangtec. TPA showed sensitivity rates of 31.8%, 42.4% and 51.5% while CA-125 showed sensitivities of 16.3%, 18.6% and 25.6% at specificity levels of 100%, 95% and 90% respectively. Combined determination of the two markers resulted in some improvement in sensitivity. For follow-up of breast cancer patients after surgery both markers were of value and showed near-identical patterns.
机译:测定了86例患者的血清TPA和CA-125(66例乳腺癌代表疾病的不同阶段和等级以及20例正常健康对照)。使用BYK Sangtec提供的L1A试剂估算TPA和CA-125。在特异性水平分别为100%,95%和90%时,TPA的敏感性分别为31.8%,42.4%和51.5%,而CA-125的敏感性分别为16.3%,18.6%和25.6%。两种标记物的组合测定导致灵敏度有所提高。对于乳腺癌患者术后的随访,两种标记物都很有价值并且显示出几乎相同的模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号